By HCATampa, 12:40 pm on June 25, 2021

Alzheimer’s patients and their loved ones now have a renewed cause for hope. For the first time in nearly two decades, the U.S. Food and Drug Administration (FDA) has approved an Alzheimer’s medication that slows the progression of the disease. What Is Alzheimer’s Disease? Alzheimer’s disease is an irreversible brain disorder involving parts of the brain that control memory, thoughts, and language. It is a progressive disease that typically begins with mild memory loss and advances to the inability to hold a conversation or perform basic tasks. Experts estimate approximately 6 million Americans have Alzheimer’s disease. Most Alzheimer’s patients are older than 65, but the disease can also affect people younger than 65. The exact causes of Alzheimer’s disease are not fully…